STAT3-IN-10

STAT3-IN-8

STAT3-IN-11

STAT3-IN-13

STAT3-IN-8

STAT3 inhibitor 3

STAT3-IN-1

N-(9-((2S,3S,3aR,4aS,5aR,5bR)-3-Fluoro-3a,5a-dihydroxyoctahydrocyclopropa[4,5]cyclopenta[1,2-b]furan-2-yl)-9H-purin-6-yl)benzamide

Hexadecanoic acid, 1,1'-[(1R)-1-[15-(11,12-didehydrodibenz[b,f]azocin-5(6H)-yl)-3-hydroxy-3-oxido-8,11,15-trioxo-2,4-dioxa-7,12-diaza-3-phosphapentadec-1-yl]-1,2-ethanediyl] ester

2,2-Dimethyl-1-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4,5,6,7-tetrahydro-1H-indol-1-yl)propan-1-one

2-(Trimethylsilyl)ethyl 4-(((4-nitrophenoxy)carbonyl)oxy)-3,4,7,8-tetrahydroazocine-1(2H)-carboxylate

2-Methyl-4-{pyrazolo[1,5-a]pyridin-3-yl}butanoic acid

(4S,5R)-2-(2'-(Diphenylphosphanyl)-[1,1'-biphenyl]-2-yl)-4,5-diphenyl-4,5-dihydrooxazole

(9H-Fluoren-9-yl)methyl ((S)-1-(((S)-5-guanidino-1-((4-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenyl)amino)-1-oxopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate

3,11-Dioxo-2,10-dioxa-4,12-diazaheptadecan-17-yl (1-hydroxy-7,15-dioxo-8,16-dioxa-6,14-diazahenicosan-21-yl)carbamate

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)tetrazolo[1,5-a]pyridine

(S)-4-Benzyl-2-((S)-2-(diphenylphosphanyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)-4,5-dihydrooxazole